Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Dromeus Capital Group launched its Greek Advantage Fund last October, and in its first 12 months, has returned 107%. “Launching our fund during that period of extraordinary uncertainty, not only for Greece but for the Eurozone as a whole, may have seemed a risky proposition,” co-founder Achilles Risvas said. “It was certainly a non-consensus idea, but the low level of asset prices meant we were absolutely convinced that we had valuation on our side.” In one case, Greek bank warrants, Dromeus has enjoyed a 250% return, following the banks’ recapitalization. The fund has also benefitted from some non-Greek investments, including in pianomaker Steinway Musical Instruments, which was bought by hedge fund Paulson & Co. And, Risvas says, there’s further room to grow.